Signaling Pathways - IRAK - EZH2 - MET
清除全部
-
B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂 -
B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂 -
B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂 -
A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met（野生型/突变型）抑制剂 -
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met抑制剂 -
A5703 BMS-777607Target: METSummary: 强效的c-Met选择性抑制剂 -
A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂 -
A2678 SU112742 CitationTarget: METSummary: C-Met抑制剂 -
A3573 LY2801653Target: METSummary: MET抑制剂 -
A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂